A RCT to Determine the Effect of ENDS Flavor Availability on Abstinence Within Smokers
Public ClinicalTrials.gov record NCT07172438. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Controlled Trial to Determine the Effect of Flavor Availability on Abstinence With an Electronic Nicotine Delivery System in Primary Combustible Cigarette Smokers.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The overall purpose of this study will be to assess primary combustible cigarette users' abstinence from smoking their usual brand of combustible cigarettes at the end of the study, when provided with an electronic nicotine delivery system (ENDS) power unit (2) and varying levels of access to tobacco-flavored, menthol-flavored, or non-tobacco/non-menthol-flavored cartridge-based e-liquids (collectively referred to as the investigational product) within their assigned study arm over a three-month (ninety-day) period.
Study identification
- NCT ID
- NCT07172438
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 668 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 21 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 16, 2025
- Primary completion
- Jan 13, 2026
- Completion
- Jan 13, 2026
- Last update posted
- Feb 26, 2026
2025 – 2026
United States locations
- U.S. sites
- 27
- U.S. states
- 9
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| CRG Test America-Phoenix | Chandler | Arizona | 85226 | — |
| C&C-Fort Smith | Fort Smith | Arkansas | 72908 | — |
| Research America Orlando | Altamonte Springs | Florida | 32701 | — |
| C&C-Tampa | Clearwater | Florida | 33761 | — |
| Sago Orlando | Maitland | Florida | 32751 | — |
| CRG Test America-Pembroke Pines | Miami | Florida | 33026 | — |
| CRG Test America-Ormond Beach | Ormond Beach | Florida | 32174 | — |
| C&C-Plantation | Plantation | Florida | 33388 | — |
| C&C-Sebring | Sebring | Florida | 33870 | — |
| C&C-Tallahassee | Tallahassee | Florida | 32301 | — |
| CRG Test America-Tampa | Tampa | Florida | 33609 | — |
| C&C-Lombard | Lombard | Illinois | 60148 | — |
| C&C-Troy | Troy | Michigan | 48083 | — |
| CRG Test America-St. Peters | City of Saint Peters | Missouri | 63376 | — |
| C&C-Richmond Heights | St Louis | Missouri | 63117 | — |
| Sago St. Louis | St Louis | Missouri | 63131 | — |
| Sago Philadelphia | Philadelphia | Pennsylvania | 19103 | — |
| C&C-Philadelphia | Philadelphia | Pennsylvania | 19154 | — |
| Southern Solutions Knoxville | Knoxville | Tennessee | 37922 | — |
| C&C-Arlington | Arlington | Texas | 76015 | — |
| Sago Dallas | Dallas | Texas | 75254 | — |
| CRG Test America-Grapevine | Grapevine | Texas | 76051 | — |
| Sago Houston | Houston | Texas | 77027 | — |
| C&C-Humble | Humble | Texas | 77338 | — |
| C&C-Mesquite | Mesquite | Texas | 75150 | — |
| C&C-San Antonio | San Antonio | Texas | 78216 | — |
| C&C-San Antonio | San Antonio | Texas | 78224 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07172438, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 26, 2026 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07172438 live on ClinicalTrials.gov.